Physician profile
Rene Harper
NPI 1710055132
$1,225.64
in general payments reported to CMS, 2019-2025
18 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $35.71 · 2022: $97.87 · 2023: $398 · 2024: $20.33 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $328.25 | 2019-2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Mannkind Corporation | $168.07 | 2019-2023 | Afrezza |
| Abbott Laboratories | $159.22 | 2019-2022 | |
| Medtronic, INC. | $135.39 | 2023 | Minimed 780g |
| Amgen INC. | $64.71 | 2025 | Evenity, Tepezza |
| Kyowa Kirin, INC. | $47.88 | 2024-2025 | Crysvita |
| Medtronic Minimed, INC. | $40.80 | 2019 | |
| Sequel Med Tech, LLC | $39.27 | 2025 | Twiist |
| Novo Nordisk INC | $34.99 | 2025 | Ozempic |
| Recordati_rare_diseases_inc. | $34.04 | 2025 | Isturisa |
| Tandem Diabetes Care, INC. | $33.25 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $30.28 | 2025 | Korlym |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.48 | 2022 | |
| Insulet Corporation | $18.99 | 2023 | Omnipod |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $17.82 | 2022 | |
| Merck Sharp & Dohme LLC | $17.49 | 2023 | |
| Lilly USA, LLC | $15.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.